Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
  1. 4 Open-market sale Chief Financial Officer sold 141 shares at $23.51 ($3,315)
  2. 4 Open-market sale Chief Medical Officer sold 70 shares at $23.51 ($1,646)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Medical Officer sold 349 shares at $27.51 ($9,602)
  11. 4 Open-market sale Chief Financial Officer sold 358 shares at $25.07 ($8,975)
  12. 4 Exercise or conversion Chief Executive Officer acquired 35,229 shares (option exercise)
  13. 4 Open-market sale Chief Medical Officer sold 70 shares at $24.35 ($1,705)
  14. 4 Open-market sale Chief Financial Officer sold 141 shares at $24.35 ($3,433)
  15. 4 Open-market sale Chief Operating Officer sold 145 shares at $24.35 ($3,531)
  16. 4 Shares withheld for taxes Chief Medical Officer gave up 345 shares (to pay taxes)
  17. 4 Open-market sale Chief Financial Officer sold 360 shares at $29.68 ($10,685)
  18. 4 Open-market sale Chief Operating Officer sold 612 shares at $28.04 ($17,160)
  19. 3/A Insider 3/A
  20. 3/A Insider 3/A

Page 9 of 12 · 233 filings